Working Groups

Vaccinations

Update of the 2008 Recommendations

Vaccinations remain one of the most effective measures against infectious diseases. In the past, numerous infectious diseases, especially measles, mumps, rubella, poliomyelitis, diphtheria and tetanus, have largely been kept under control by the use of vaccines. For the major epidemics HIV/AIDS, malaria and hepatitis C, no vaccines are available yet. Based on a symposium on vaccinations that took place on 8 November 2010, the working group revised the Leopoldina statements and recommendations from the year 2008.

Among other things, the report dealt with the following points:

The current state of biomedical research and research into the development of new vaccines
Authorization procedures and requirements, and vaccination recommendations
Effectiveness and cost/benefit assessment of vaccinations
The tasks and interests of science, politics and industry
The mission and interests of science, politics and industry
Knowledge and attitudes regarding infections and vaccinations in the population

Institution

National Academy of Sciences Leopoldina

Spokespersons of the Working Group

Prof. Dr. Stefan H. E. Kaufmann ML, Max-Planck-Institut für Infektionsbiologie Berlin
Prof. Dr. Jörg Hacker ML, Former President of the German Academy of Sciences Leopoldina – National Academy of Sciences, Halle (Saale)

Members of the Working Group

Prof. Dr. Cornelia Betsch, Universität Erfurt, Center for Empirical Research in Economics and Behavioral Science
Prof. Dr. Klaus Cichutek, Paul-Ehrlich-Institut, Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel
Prof. Dr. Hans-Dieter Klenk ML, Institut für Virologie, Philipps-Universität Marburg
Prof. Dr. Gérard Krause, Abteilungsleiter Epidemiologie, Helmholtz-Zentrum für Infektionsforschung, Braunschweig
Prof. Dr. Anja Mehnert, Department für Psychische Gesundheit, Selbständige Abteilung Medizinische Psychologie und Medizinische Soziologie, Sektion Psychosoziale Onkologie, Universitätsklinikum Leipzig
Prof. Dr Thomas Mertens, Institut für Virologie, Universitätsklinikum Ulm
Prof. Dr. Thomas C. Mettenleiter ML, Friedrich-Löffler-Institut, Bundesforschungsinstitut für Tiergesundheit
Prof. Dr. Andreas Radbruch ML, Deutsches Zentrum für Rheumatische Erkrankungen
Dr. Klaus Stöhr, Basel
Dr. Ole Wichmann, Fachgruppe Impfprävention am Robert Koch Institut, Berlin
Prof. Dr. Lothar-Heinz Wieler ML, Präsident Robert-Koch-Institut, Berlin